Clinical Trials Directory

Trials / Terminated

TerminatedNCT00421967

Postoperative Analgesia After Total Knee Arthroplasty

Postoperative Analgesia After Total Knee Arthroplasty. A Comparison of Continuous Epidural Infusion and Wound Infiltration With Continuous Intraarticular Infusion

Status
Terminated
Phase
Phase 4
Study type
Interventional
Enrollment
80 (actual)
Sponsor
University of Aarhus · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Total knee arthroplasty (TKA) is associated with moderate to severe postoperative pain. Although epidural treatment provides good and reliable postoperative pain relief after THA, it may cause urinary retention, nausea, hypotension, diminished muscle control, and delayed mobilization. The challenge of new analgesic regimes is to reduce the occurrence of side effects while maintaining adequate pain relief and maximum muscle control. A relatively new method to provide postoperative pain relief after TKA is local infiltration analgesia combined with single-shot injection(s) or continuous infusion of local anesthetics into the surgical site. As local infiltration analgesia combined with continuous intraarticular infusion compared with continuous epidural infusion has not been evaluated, our study was designed to determine whether this technique could enhance analgesia and improve patient outcome after TKA. This study compares continuous epidural infusion of Ropivacaine and intravenous Ketorolac with local infiltration analgesia with Ropivacaine, Ketorolac and Adrenaline combined with continuous intraarticular infusion of Ropivacaine and Ketorolac.

Conditions

Interventions

TypeNameDescription
DRUGRopivacaine, Ketorolac, adrenalineInfiltration: 150 ml Ropivacaine 2mg/ml added 1 ml Ketorolac 30 mg/ml and 0,5 ml Adrenaline 1 mg/ml Intraarticular infusion: 4 ml/h 384 mg Ropivacaine 60 mg Ketorolac
DRUGRopivacaine KetorolacEpidural infusion: 4 ml/h 384 mg Ropivacaine I.V. Ketorolac 90 mg

Timeline

Start date
2007-01-01
Primary completion
2008-03-01
Completion
2008-04-01
First posted
2007-01-15
Last updated
2008-05-07

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT00421967. Inclusion in this directory is not an endorsement.